HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Marc P. Sakwa Robert W. Emery Francis L. Shannon Jeffrey M. Altshuler Arlen R. Holter Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sakwa, M. P. Articles by Holter, A. R. Search for Related Content PubMed Articles by Sakwa, M. P. Articles by Holter, A. R. Related Collections Cardiac - physiology Cardiac - other Extracorporeal circulation

J Thorac Cardiovasc Surg 2009;137:481-485
© 2009 The American Association for Thoracic Surgery

Cardiopulmonary Support and Physiology

Coronary artery bypass grafting with a minimized cardiopulmonary bypass circuit: A prospective, randomized trial

^a Division of Cardiovascular Surgery, William Beaumont Hospital, Royal Oaks, Mich
^b Division of Cardiovascular Surgery, St Joseph's Hospital, St Paul, Minn

Received for publication April 17, 2008; revisions received August 4, 2008; accepted for publication August 27, 2008.

^_* Address for reprints: Robert W. Emery, MD, 640 Jackson St, MS: 11503K, St Paul, MN 55101. (Email: robert.w.emery{at}healthpartners.com).

Objective: The study was designed to determine differences in blood loss and transfusion associated with a minimized cardiopulmonary bypass circuit versus a standard bypass circuit.

Methods: From February 2005 through April 2006, 199 patients were randomized to undergo coronary artery bypass grafting with a standard cardiopulmonary bypass circuit (Medtronic, Inc., Minneapolis, Minn) or a minimized bypass circuit, the Medtronic Resting Heart Circuit. Laboratory perimeters (hemoglobin and platelet count), were measured at baseline, after initiation of cardiopulmonary bypass, and on intensive care unit admission. Lowest values recorded were noted. Blood administration was controlled by study-specific protocol orders, (transfusion for hemoglobin <8mg%). Patient demographic data were retrieved from the Society of Thoracic Surgeons database. Blood product administration was recorded during hospital admission, and chest tube drainage as total output collected from operating room to discontinuation. Continuous variables were tested with a Wilcoxin rank test, and categoric variables with X ² and Fisher's exact tests.

Results: Hematocrit, equivalent at baseline, was higher in minimized circuit cohort at lowest point during cariopulmonary bypass (31.5% ± 3.9% vs. 25.5% ± 3.7%), after protamine (31.6% ± 3.9% vs 29.2% ± 3.7%), and on intensive care unit arrival (35.2% ± 4.1% vs 31.8% ± 3.5%, P < .001). Similarly, platelet count was higher in minimized circuit group on intensive care unit arrival, as was lowest platelet count recorded (170 x 10³ ± 48 cells/mm³ vs 107 x 10³ ± 28 cells/mm³, P < .0001). Time to extubation was shorter in minimized circuit group (848 ± 737 minutes vs. 526 ± 282 minutes, (P < .01), and total chest tube drainage was lower (1124 ± 647 mL vs. 506 ± 214 mL, P < .01). Fewer red blood cells (148 vs 19 units) were given in minimized circuit group (P < .0001).

Conclusions: A minimized cardiopulmonary bypass circuit provides less hemodilution, platelet consumption, chest tube output and lower post-operative blood loss than standard cardiopulmonary bypass. Red blood cell usage was also less. All differences are advantageous.